The use of a cystic fibrosis patient registry to assess outcomes and improve cystic fibrosis care in Germany

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 6, 2011, Pages 473-477

  Stern, Martin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

benchmarking; cystic fibrosis; outcome research; patient registry; quality improvement

Indexed keywords

BODY HEIGHT; BODY MASS; BODY WEIGHT; CYSTIC FIBROSIS; DISEASE REGISTRY; GERMANY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LUNG FUNCTION; MORTALITY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT CARE; PSEUDOMONAS INFECTION; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TOTAL QUALITY MANAGEMENT;

BENCHMARKING; CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; FEMALE; GERMANY; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY ASSURANCE, HEALTH CARE; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; REGISTRIES;

EID: 80053360266     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834b6b72     Document Type: Review

References (30)

1. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41:583-591.
2. Schechter MS, Margolis P. Improving subspecialty healthcare: lessons from cystic fibrosis. J Pediatr 2005; 147:295-301. (Pubitemid 41345756)
3. Quinton HB, OConnor GT; for the Northern New England CV Cystic Fibrosis Consortium. Current issues in quality improvement in cystic fibrosis. Clin Chest Med 2007; 28:459-472. (Pubitemid 46654483)
4. Stern M, Wiedemann B, Wenzlaff P; on behalf of the German Cystic Fibrosis Quality AssessmentGroup. From registry to quality management: the German Cystic Fibrosis Quality Assessment Project 1995-2006. Eur Respir J 2008; 31:29-35.
5. Konstan MW, VanDevanter DR, Rasouliyan L, et al.; for the Scientific Advisory Group and Investigators and Coordinators of the Epidemiology Study of Cystic Fibrosis. Trends in the use of routine therapies in cystic fibrosis: 1995-2005. Pediatr Pulmonol 2010; 45:1167-1172.
6. Schechter MS, Gutierrez HH. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr 2010; 22:296-301.
7. Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from Cystic Fibrosis Registries. 1: Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009; 8:229-237.
8. McCormick J, Mehta G, Olesen HV, et al. Comparative demographics of the European Cystic Fibrosis Population: a cross-sectional database analysis. Lancet 2010; 375:1007-1013.
9. Sheppard BN. The European Cystic Fibrosis Patient Registry: the power of sharing data. J Cyst Fibros 2010; 9:S1-S2.
10. Mehta G, Macek M Jr, Metha A, On behalf of the European Registry Working Group. Cystic Fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 2010; 9:S5-S21.
11. Sens B, Stern M. (Hrsg.). Qualitä tssicherung Mukoviszidose. Bad Honnef: Hippocampus Verlag; 2010.
12. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross section study. BMJ 1998; 316:1771-1775. (Pubitemid 28269150)
13. Post PN, Wittenberg J, Burgers JS. Do specialized centers and specialists produce better outcomes for patients with chronic diseases than primary care generalists? A systemic review. Int J Qual Healthcare 2009; 21:387-396.
14. Tiddens H. Quality improvement in your CF Centre: taking care of care. J Cyst Fibros 2009; 8 (Suppl 1):S2-S5.
15. Knudsen PK, Olesen HV, Hiby N, et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 2009; 8:135-142.
16. Wiedemann B, Paul KD, Stern M, et al., on behalf of the German CFQA Group. Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis. Eur J Clin Nutr 2007; 61:759-768. (Pubitemid 47232356)
17. Zemanick ET, Harris JK, Conway S, et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros 2010; 9:1-16.
18. Liou TG, Elkin EP, Pasta EJ, et al. Year-to-year changes in lung functions in individuals with cystic fibrosis. J Cyst Fibros 2010; 9:250-256.
19. Konstan MW, Wagener JS, Yegin A, et al. Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint. J Cyst Fibros 2010; 9:332-338.
20. Wiedemann B. Delta FEV1. In: Qualitä tssicherung Mukoviszidose. Bad Honnef: Hippocampus Verlag; 2010. pp. 72-76.
21. Abbott J, Hart A, Morton AM, et al. Can health-related quality of life predict survival in adults with cystic fibrosis? Am J Respir Crit Care Med 2009; 179:54-58.
22. Schmidt A, Wenninger K, Niemann N, et al. Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R. Health Qual Life Outcomes 2009; 7:97. doi:10.1186/1477-7525-7-97.
23. Kraynack NC, McBride JT. Improving care at cystic fibrosis centers through quality improvement. Respir Crit Care Med 2009; 30:547-558.
24. McPhail GL, Weiland J, Acton JD, et al. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med 2010; 164:957-960. 25
25. Ernst MM, Wooldridge JL, Conway E, et al. Using quality improvement science to implement a multidisciplinary behavioral intervention targeting pediatric inpatient airway clearance. J Pediatr Psychol 2010; 35: 14-24. 26
26. Leonard A, Davis E, Rosenstein BJ, et al. Description of a standardized nutrition classification plan and its relation to nutritional outcomes in children with cystic fibrosis. J Pediatr Psychol 2010; 35:6-13.
27. Stark LJ, Opipari-Arrigan L, Quittner AL, et al. Effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF. Pediatr Pulmonol 2011; 46:31-35.
28. Stern M, Niemann N, Wenzlaff P. Benchmarking. In: Qualitä tssicherung Mukoviszidose. Bad Honnef: Hippocampus Verlag; 2010. pp. 69-71.
29. Niemann N, Wenzlaff P, Stern M. Benchmarking in der Versorgung von Mukoviszidose-Patienten/innen -Ein etabliertes Instrument zur Verbesserung der Patientenversorgung. German J Evidence Quality Healthcare 2011 (in press).
30. Stern M, Niemann N, Wiedemann B, Wenzlaff P; on behalf of the German CFQA Group. Benchmarking improves quality in cystic fibrosis care: a Pilot Project involving 12 Centres. Int J Qual Healthcare 2011; 23:349-356. doi: 10.1093/intqhc/mzr017.